A new Moffitt Cancer Center study suggests a widely used genomic test can more accurately identify which men with early prostate cancer are at high risk for their disease to come back quickly after ...
I was one in eight. One in eight men will be diagnosed with prostate cancer in their lifetime. Nah, I was one in six. One in ...
A new Moffitt Cancer Center study suggests a widely used genomic test can more accurately identify which men with early ...
A prostate-specific antigen (PSA) test is a blood test that measures a protein released in the blood by prostate cells. Both normal and cancerous prostate cells release the protein. Most of the time, ...
The Advertising Standards Authority (ASA) has prohibited advertisements for prostate supplements and home testing kits, fearing they could mislead vulnerable individuals or deter them from appropriate ...
Adverts for at-home prostate cancer tests that claim to offer a diagnosis, including one that suggests patients can “skip the doctors” have been banned by watchdogs. The Advertising Standards ...
IsoPSA offers a more precise prostate cancer screening by analyzing PSA protein isoforms, reducing false positives compared to traditional PSA tests. Clinical studies show IsoPSA's superior diagnostic ...
The FDA has approved a novel diagnostic for prostate cancer that looks to improve upon the common screener for prostate-specific antigen, known as a PSA test. The IsoPSA blood test, developed by ...
Trump's physician said the president underwent cardiac and abdominal imaging. The White House released the results of President Donald Trump's recent advanced imaging tests on Monday, describing them ...
IsoPSA test offers improved prostate cancer risk stratification by analyzing PSA protein isoforms, enhancing specificity over traditional PSA tests. The test is included in key diagnostic guidelines, ...
IsoPSA, a blood-based test, aids in diagnosing high-grade prostate cancer by analyzing PSA protein structural variants. FDA approval was based on a large-scale, prospective study and other validation ...